Cargando…

Uterine Fibroids: Burden and Unmet Medical Need

Uterine fibroids affect a wide cross-section of the population, with prevalence, symptom severity, and overall disease burden generally higher among black women, likely due to both genetic and environmental factors. Potential symptoms of uterine fibroids include painful and excessive uterine bleedin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hendy, Ayman, Myers, Evan Robert, Stewart, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical Publishers 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193285/ https://www.ncbi.nlm.nih.gov/pubmed/29100234 http://dx.doi.org/10.1055/s-0037-1607264

Ejemplares similares

Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside
por: Aninye, Irene O., et al.
Publicado: (2021)

The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids
por: Ciebiera, Michał, et al.
Publicado: (2020)

Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid
por: Banerjee, Saswati, et al.
Publicado: (2022)

Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2023)

Understanding the Impact of Uterine Fibroids on Human Endometrium Function
por: Navarro, Antonia, et al.
Publicado: (2021)

Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids(†)
por: Ali, Mohamed, et al.
Publicado: (2017)

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
por: Venable, Sateria R., et al.
Publicado: (2023)

Burden of Uterine Fibroids: An African Perspective, A Call for Action and Opportunity for Intervention
por: Igboeli, P, et al.
Publicado: (2019)

Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance
por: Ciebiera, Michał, et al.
Publicado: (2020)

Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids
por: Omar, Mona, et al.
Publicado: (2019)

GnRH analogs for the treatment of heavy menstrual bleeding associated with uterine fibroids
por: Madueke-Laveaux, Obianuju Sandra, et al.
Publicado: (2022)

Uterine fibroids — Causes, impact, treatment, and lens to the African perspective
por: Sefah, Narvella, et al.
Publicado: (2023)

Converting of Myometrial Stem Cells to Tumor-Initiating Cells: Mechanism of Uterine Fibroid Development
por: Yang, Qiwei, et al.
Publicado: (2016)

The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids
por: Ciebiera, Michał, et al.
Publicado: (2020)

A plain language summary of the long-term relugolix combination therapy study for uterine fibroids
por: Al-Hendy, Ayman, et al.
Publicado: (2023)

Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
por: Yang, Qiwei, et al.
Publicado: (2021)

Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2023)

Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids
por: Yang, Qiwei, et al.
Publicado: (2023)

Uterine Fibroids or Myomata
por: Myers, J. F.
Publicado: (1903)

Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation
por: Yang, Qiwei, et al.
Publicado: (2016)

Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach)
por: Vafaei, Somayeh, et al.
Publicado: (2023)

Epigenetic Regulation in Uterine Fibroids—The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application
por: Włodarczyk, Marta, et al.
Publicado: (2022)

Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics
por: Ali, Mohamed, et al.
Publicado: (2023)

Defective expression of ATG4D abrogates autophagy and promotes growth in human uterine fibroids
por: Andaloussi, Abdeljabar El, et al.
Publicado: (2017)

Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study
por: Roshdy, Eman, et al.
Publicado: (2013)

A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids
por: Leyland, Nicholas, et al.
Publicado: (2022)

The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2016)

Current medical treatment of uterine fibroids
por: Sohn, Geum Seon, et al.
Publicado: (2018)

Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids
por: Stewart, Elizabeth A., et al.
Publicado: (2022)

Uterine Fibroids
Publicado: (1903)

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
por: Al-Hendy, Ayman, et al.
Publicado: (2021)

Quality of Life in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids: Baseline Disease Burden from Elaris UF-1 and UF-2
por: Gillispie, V., et al.
Publicado: (2020)

Operations on Uterine Fibroids
Publicado: (1901)

The Treatment of Uterine Fibroids
por: Hicks, H. T.
Publicado: (1907)

The Treatment of Uterine Fibroids
Publicado: (1900)

The Treatment of Uterine Fibroids
Publicado: (1903)

Uterine Fibroids and Diet
por: Tinelli, Andrea, et al.
Publicado: (2021)

Uterine Fibroids and Infertility
por: Freytag, Damaris, et al.
Publicado: (2021)

Treatment of Uterine Fibroids
por: Goelet, Augustin H.
Publicado: (1894)

The Treatment of Uterine Fibroids
por: Hardon, Virgil O.
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_2vtedlc3epbf9paua3vh2k7nur